World Healthy Lifestyle Awareness Day: The Power of AI for Personalised Health

By Sumona Bose

February 15, 2024

Introduction

In today’s fast-paced world, where hectic schedules and demanding lifestyles have become the norm, maintaining a healthy lifestyle has never been more important. As we commemorate World Healthy Lifestyle Awareness Day (15th of February), it is crucial to recognise the role that artificial intelligence (AI) and Machine Learning (ML).  ML is a subset of AI which can be positioned to differentiate between correct and incorrect categorisations. The power of AI in personalised health can improve our attitudes towards health accordingly.

AI has made significant strides in recent years, enabling the development of sophisticated applications and tools that can assess trends in outcome-based research. AI advancements pave the way for healthcare interventions such as biological evaluations, diagnostics and predictions through devices. This has led to a more personalised collection of data and real-time feedback from customers.

Diseases 11 00097 g001 550
Figure 1: A schematic representation of the most commonly known AI methods.

Nutrition Assessments and AI

One area where AI can have a profound impact is in nutrition assessments. By collecting and evaluating data about dietary intake, AI systems can provide tailored diets that fit an individual’s behaviours. Factors such as age, gender, microbiota, genetics, metabolism, and lifestyle habits can all influence how individuals respond to food nutrients. The adoption of AI in the field of nutrition could pave the way for the development of personalised nutrition plans. This can eventually lead to better health outcomes at both the individual and national levels. AI technologies can enable precise customised dietary recommendations and promote health through predictive and preventive guidelines. This facilitates the management of diseases in a more effective manner.

AI Enabling Holistic Health Interventions

AI can assist physicians in selecting appropriate therapies, adjusting doses in a timely manner, and identifying patients who require more comprehensive or urgent examinations. By reducing the time spent in face-to-face visits and streamlining healthcare processes, AI can alleviate the workload of physicians and decrease waiting times in medical centres. This, in turn, can lead to a reduction in overall healthcare costs. The power of AI in personalised health delivers context specific health outcomes.

Conclusion

It is important to address certain challenges, related to patient privacy whilst acknowledging AI’s utility. Healthcare institutions and research collaborations produce methods in which AI is implemented responsibly and ethically. As we celebrate World Healthy Lifestyle Awareness Day, let us celebrate AI and personalised healthcare.

Reference url

Recent Posts

Blinatumomab benefit assessment
            

Blinatumomab Benefit Assessment for ALL and Health Economics

🚀 How does a groundbreaking therapy change the landscape of acute lymphoblastic leukemia treatment?

The recent benefit assessment of Blinatumomab by the German Federal Joint Committee reveals critical insights into its potential as a consolidation therapy for adults with Philadelphia chromosome-negative B-cell precursor ALL. With its orphan drug status promising automatic benefits, the article explores the implications of its high cost and economic impacts, shedding light on the balance needed between innovation and sustainability in healthcare.

Jump into the full analysis to understand how this could impact clinical practice and health economics.

#SyenzaNews #HealthEconomics #MarketAccess

Enhertu reimbursement analysis
                 

Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges

💡 How do we balance groundbreaking cancer treatments with budget realities?

The recent analysis by the Dutch Healthcare Institute on Enhertu shines a light on the complexities of integrating innovative therapies for HER2-low metastatic breast cancer into national insurance packages. While the clinical efficacy is evident, the substantial cost implications and demand for steep price reductions bring significant challenges to market access.

Explore the nuances of this vital discussion on clinical effectiveness, economic evaluation, and the future of pricing strategies in oncology.

#SyenzaNews #HealthEconomics #MarketAccess

drug price comparison
 

Global Drug Price Gaps Demand Better Drug Pricing Analysis

💊 International drug price comparison reveal stark price gaps—the U.S. pays 4.2 times more for brand-name drugs than OECD peers.

But are these studies fueling a market collapse or opening a strategic opportunity for sustainable pricing in the U.S. and globally?

Discover the shortcomings of international pricing comparisons and how robust drug pricing analysis can help balance access, affordability, and profitability in a complex market.

#SyenzaNews #healthcare #pricing

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.